OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 80 citing articles:

From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
Yaojie Fu, Shanshan Liu, Shan Zeng, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 339

Excess body weight: Novel insights into its roles in obesity comorbidities
Xiang Zhang, Suki Ha, Harry Cheuk-Hay Lau, et al.
Seminars in Cancer Biology (2023) Vol. 92, pp. 16-27
Open Access | Times Cited: 116

FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2
Meng Xie, Zhuoying Lin, Xiaoyu Ji, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 1, pp. 109-125
Open Access | Times Cited: 95

Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets
Joshua S. Fleishman, Sunil Kumar
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 82

Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy
Tianchen Guo, Junfen Xu
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 3, pp. 1095-1116
Open Access | Times Cited: 31

A Molecular Perspective on HIF-1α and Angiogenic Stimulator Networks and Their Role in Solid Tumors: An Update
Anuja Gajanan Magar, Vivek Kumar Morya, Mi Kyung Kwak, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3313-3313
Open Access | Times Cited: 26

Alternative Splicing in Angiogenesis
Elizabeth Bowler, Sebastian Oltean
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2067-2067
Open Access | Times Cited: 96

Current and potential treatments for primary biliary cholangitis
Raj A. Shah, Kris V. Kowdley
˜The œLancet. Gastroenterology & hepatology (2019) Vol. 5, Iss. 3, pp. 306-315
Closed Access | Times Cited: 89

HMGA1 induces FGF19 to drive pancreatic carcinogenesis and stroma formation
Lionel Chia, Bowen Wang, Jung‐Hyun Kim, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 6
Open Access | Times Cited: 29

R-Spondin 2 governs Xenopus left-right body axis formation by establishing an FGF signaling gradient
Hye-Yoon Lee, Celine Marie Camuto, Christof Niehrs
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9

Dissecting the Role of the FGF19-FGFR4 Signaling Pathway in Cancer Development and Progression
Yanan Liu, Meng Cao, Yuepiao Cai, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 69

Nonsteroidal FXR Ligands: Current Status and Clinical Applications
Christian Gege, Eva Hambruch, Nina Hambruch, et al.
Handbook of experimental pharmacology (2019), pp. 167-205
Closed Access | Times Cited: 66

Obeticholic Acid: An Update of Its Pharmacological Activities in Liver Disorders
Stefano Fiorucci, Cristina Di Giorgio, Eleonora Distrutti
Handbook of experimental pharmacology (2019), pp. 283-295
Closed Access | Times Cited: 66

Fibroblast Growth Factor Receptor Signaling in Skin Cancers
Małgorzata Czyż
Cells (2019) Vol. 8, Iss. 6, pp. 540-540
Open Access | Times Cited: 59

Development of an Immune-Related Risk Signature for Predicting Prognosis in Lung Squamous Cell Carcinoma
Denggang Fu, Biyu Zhang, Lei Yang, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 48

An update of new small-molecule anticancer drugs approved from 2015 to 2020
Xiaoxia Liang, Pan Wu, Qian Yang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 220, pp. 113473-113473
Closed Access | Times Cited: 41

The synthesis review of the approved tyrosine kinase inhibitors for anticancer therapy in 2015–2020
Xiaoxia Liang, Qian Yang, Pan Wu, et al.
Bioorganic Chemistry (2021) Vol. 113, pp. 105011-105011
Closed Access | Times Cited: 37

XAI-CNVMarker: Explainable AI-based copy number variant biomarker discovery for breast cancer subtypes
Sheetal Rajpal, Ankit Rajpal, Manoj Agarwal, et al.
Biomedical Signal Processing and Control (2023) Vol. 84, pp. 104979-104979
Closed Access | Times Cited: 16

The Breast Cancer Single-Cell Atlas: Defining cellular heterogeneity within model cell lines and primary tumors to inform disease subtype, stemness, and treatment options
Arpit Dave, Daniel Charytonowicz, Nancy Francoeur, et al.
Cellular Oncology (2023) Vol. 46, Iss. 3, pp. 603-628
Open Access | Times Cited: 14

FGF19/FGFR4 signaling contributes to hepatocellular carcinoma survival and immune escape by regulating IGF2BP1-mediated expression of PD-L1
Chaoqin Guo, Nana Zhou, Yisong Lu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 115955-115955
Open Access | Times Cited: 13

Transcriptome signatures of host tissue infected with African swine fever virus reveal differential expression of associated oncogenes
Rajib Deb, Gyanendra Singh Sengar, Joyshikh Sonowal, et al.
Archives of Virology (2024) Vol. 169, Iss. 3
Open Access | Times Cited: 4

Receptor tyrosine kinases and heparan sulfate proteoglycans: Interplay providing anticancer targeting strategies and new therapeutic opportunities
Cinzia Lanzi, Giuliana Cassinelli
Biochemical Pharmacology (2020) Vol. 178, pp. 114084-114084
Closed Access | Times Cited: 30

Dark and bright side of targeting fibroblast growth factor receptor 4 in the liver
Raffaella Maria Gadaleta, Antonio Moschetta
Journal of Hepatology (2021) Vol. 75, Iss. 6, pp. 1440-1451
Open Access | Times Cited: 24

Page 1 - Next Page

Scroll to top